GlobeNewswire: Warner Chilcott Contains the last 10 of 73 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T09:33:00ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2013/09/11/572795/10048123/en/Announcement-Under-Irish-Takeover-Rules.html?f=22&fvtc=4&fvtv=8129Announcement Under Irish Takeover Rules2013-09-11T12:30:00Z<![CDATA[THIS ANNOUNCEMENT IS BEING MADE SOLELY TO COMPLY WITH THE REQUIREMENTS OF THE IRISH TAKEOVER RULES. THE INFORMATION SET OUT HEREIN CONCERNING THE RESULTS OF WARNER CHILCOTT'S SHAREHOLDER MEETINGS ON SEPTEMBER 10, 2013 IS IDENTICAL TO THAT SET OUT IN WARNER CHILCOTT'S FORM 8-K FILED ON SEPTEMBER 10, 2013]]>https://www.globenewswire.com/news-release/2013/08/29/570250/10046623/en/Three-Leading-Independent-Advisory-Firms-Recommend-Shareholders-Vote-FOR-Proposed-Acquisition-of-Warner-Chilcott-by-Actavis.html?f=22&fvtc=4&fvtv=8129Three Leading Independent Advisory Firms Recommend Shareholders Vote FOR Proposed Acquisition of Warner Chilcott by Actavis2013-08-29T21:00:32Z<![CDATA[DUBLIN, Ireland, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that all three leading independent proxy advisory firms — Institutional Shareholder Services (ISS), Glass Lewis and Egan-Jones — have recommended that Warner Chilcott shareholders vote in favor of adopting the resolutions necessary to approve the acquisition of Warner Chilcott by Actavis, Inc. (NYSE:ACT).]]>https://www.globenewswire.com/news-release/2013/07/31/563722/10042808/en/Announcement-Under-Irish-Takeover-Rules-Revision-to-Relevant-Securities-in-Issue.html?f=22&fvtc=4&fvtv=8129Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue2013-07-31T21:07:05Z<![CDATA[DUBLIN, Ireland, July 31, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "]]>https://www.globenewswire.com/news-release/2013/07/25/562275/10041764/en/Warner-Chilcott-Announces-FDA-Approval-of-New-Oral-Contraceptive.html?f=22&fvtc=4&fvtv=8129Warner Chilcott Announces FDA Approval of New Oral Contraceptive2013-07-25T10:00:00Z<![CDATA[DUBLIN, Ireland, July 25, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the United States Food and Drug Administration (FDA) has approved LO MINASTRIN™ FE (norethindrone acetate and ethinyl estradiol chewable tablets, ethinyl estradiol tablets and ferrous fumarate tablets) for the prevention of pregnancy. The Company is currently developing the commercial launch plans for LO MINASTRIN FE.]]>https://www.globenewswire.com/news-release/2013/07/24/562160/10041663/en/Warner-Chilcott-Reports-Operating-Results-for-the-Quarter-Ended-June-30-2013.html?f=22&fvtc=4&fvtv=8129Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 20132013-07-24T20:10:00Z<![CDATA[Revenue Growth of DELZICOL and LO LOESTRIN FE Drive Strong Second Quarter 2013 Financial Results DUBLIN, Ireland, July 24, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended June 30, 2013.]]>https://www.globenewswire.com/news-release/2013/07/19/561373/10041119/en/Warner-Chilcott-Announces-Earnings-Release-Date-for-Second-Quarter-2013-Financial-Results.html?f=22&fvtc=4&fvtv=8129Warner Chilcott Announces Earnings Release Date for Second Quarter 2013 Financial Results2013-07-19T20:15:00Z<![CDATA[DUBLIN, Ireland, July 19, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue a press release detailing its second quarter 2013 financial results after the market close on Wednesday, July 24, 2013.]]>https://www.globenewswire.com/news-release/2013/07/03/558002/10038845/en/Announcement-Under-Irish-Takeover-Rules-Revision-to-Relevant-Securities-in-Issue.html?f=22&fvtc=4&fvtv=8129Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue2013-07-03T12:00:00Z<![CDATA[DUBLIN, Ireland, July 3, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "]]>https://www.globenewswire.com/news-release/2013/06/18/554750/10036672/en/Announcement-Under-Irish-Takeover-Rules-Revision-to-Relevant-Securities-in-Issue.html?f=22&fvtc=4&fvtv=8129Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue2013-06-18T12:00:00Z<![CDATA[DUBLIN, Ireland, June 18, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "]]>https://www.globenewswire.com/news-release/2013/05/20/548387/10033406/en/Announcement-Under-Irish-Takeover-Rules-Revision-to-Relevant-Securities-in-Issue.html?f=22&fvtc=4&fvtv=8129Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue2013-05-20T13:00:00Z<![CDATA[DUBLIN, Ireland, May 20, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "]]>https://www.globenewswire.com/news-release/2013/05/13/546531/10032484/en/Announcement-Under-Irish-Takeover-Rules-Relevant-Securities-in-Issue.html?f=22&fvtc=4&fvtv=8129Announcement Under Irish Takeover Rules Relevant Securities in Issue2013-05-13T12:00:00Z<![CDATA[DUBLIN, Ireland, May 13, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "]]>